By leveraging HealthShare's Informatic Exchange solution, Rhodes Group will create a longitudinal, standardized data repository across TriCore's laboratories.
The agency finalized recommendations for developing and validating NGS tests, and proposed a submission process for investigational IVDs in cancer Rx trials.
The collaboration will use AI to determine if patients can be grouped based on diagnostic test information, potentially leading to quicker and better diagnoses and treatments.
The addition of the patient-facing family history platform will expand and enhance Invitae's existing genome management support services, the company said.
